Guzip Biomarkers Corporation ^Company

Guzip Biomarkers Corporation is a 2018 spin-out company from Taipei Medical University. Guzip is a research-driven company looking forward to providing novel DNA methylation epigenetic biomarkers for applications in the clinic. With a view to providing health management units as the basis for personalized medicine and contributing to improving women’s health, our first project’s goal is to develop an innovative molecular diagnostic test, which named as MPap™ DNA Methylation Detection Kit, that can be used for endometrial cancer.